Abstract:Background: The fate and functions of RNAs are coordinately regulated by RNA-binding proteins (RBPs), which are often dysregulated in various cancers. Known as a splicing regulator, RNA-binding motif protein 6 (RBM6) harbors tumor-suppressor activity in many cancers; however, there is a lack of research on the molecular targets and regulatory mechanisms of RBM6. Methods: In this study, we constructed an RBM6 knock-down (shRBM6) model in the HeLa cell line to investigate its functions and molecular targets. Then we applied improved RNA immunoprecipitation coupled with sequencing (iRIP-seq) and whole transcriptome sequencing approaches to investigate the potential role and RNA targets of RBM6. Results: Using The Cancer Genome Atlas dataset, we found that higher expression of RBM6 is associated with a better prognosis in many cancer types. In addition, we found that RBM6 knockdown promoted cell proliferation and inhibited apoptosis, demonstrating that RBM6 may act as an anti-oncogenic protein in cancer cells. RBM6 can regulate the alternative splicing (AS) of genes involved in DNA damage response, proliferation, and apoptosis-associated pathways. Meanwhile, RBM6 knockdown activated type I interferon signaling pathways and inhibited the expression of genes involved in the cell cycle, cellular responses to DNA damage, and DNA repair pathways. The differentially expressed genes (DEGs) by shRBM6 and their involved pathways were likely regulated by the transcription factors undergoing aberrant AS by RBM6 knockdown. For iRIP-seq analysis, we found that RBM6 could interact with a large number of mRNAs, with a tendency for binding motifs GGCGAUG and CUCU. RBM6 bound to the mRNA of cell proliferation- and apoptosis-associated genes with dysregulated AS after RBM6 knockdown. Conclusions: In summary, our study highlights the important role of RBM6, as well as the downstream targets and regulated pathways, suggesting the potential regulatory mechanisms of RBM6 in the development of cancer.

Insights on the biological functions and diverse regulation of RNA-binding protein 39 and their implication in human diseases

Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway

RBM22, a Key Player of Pre-mRNA Splicing and Gene Expression Regulation, Is Altered in Cancer

RBM39 shapes innate immunity through transcriptional and splicing control of key factors of the interferon response

Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

Post-translational Control of RNA-Binding Proteins and Disease-Related Dysregulation

New insights into the function and therapeutic potential of RNA-binding protein TRBP in viral infection, chronic metabolic diseases, brain disorders and cancer

Novel Insight into the Regulatory Roles of Diverse RNA Modifications: Re-defining the Bridge Between Transcription and Translation

RNA Binding Motif Protein 10 Suppresses Lung Cancer Progression by Controlling Alternative Splicing of Eukaryotic Translation Initiation Factor 4H

Targeting Dysregulated Splicing Factors in Cancer: Lessons Learned from RBM10 Deficiency.

RNA Binding Proteins as Potential Therapeutic Targets in Colorectal Cancer

The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells

Global RNA Interaction and Transcriptome Profiles Demonstrate the Potential Anti-Oncogenic Targets and Pathways of RBM6 in HeLa Cells

Role of RNA binding proteins of the Drosophila behavior and human splicing (DBHS) family in health and cancer

Functional Analysis Reveals That RBM10 Mutations Contribute to Lung Adenocarcinoma Pathogenesis by Deregulating Splicing.

Post-translational modification control of RNA-binding protein hnRNPK function

Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins

RNA-Binding Proteins in Breast Cancer: Biological Implications and Therapeutic Opportunities

Advances in the study of RNA-binding proteins in diabetic complications

RNA-binding proteins in tumor progression